Low nuclear levels of nuclear factor-kappa B are essential for KC self-induction in astrocytes: requirements for shuttling and phosphorylation

Glia
Qiwei ZhaiMartin E Dorf

Abstract

Stimulation with the chemokine KC induces an autocrine response in mouse astrocytes. A requirement for NF-kappa B was established for KC self-induction. NF-kappa B inhibitors, p65 antisense oligonucleotides, or dominant-negative Ikappa Balpha inhibited this autocrine response. Mutation of a specific kappa B site in the KC promoter also blocked KC self-induction. Chromatin immunoprecipitation and in vivo footprinting confirmed the direct binding of NF-kappa B to the KC promoter. However, neither NF-kappa B nuclear translocation, increased Ikappa B degradation, nor upregulation of NF-kappa B DNA binding activity was observed after KC stimulation. Reporter gene assays demonstrated KC-upregulated NF-kappa B transcriptional activity, and this effect was inhibited by dominant-negative IkappaBalpha. Accumulation of NF-kappaB was noted within the nucleus in the presence of nuclear export inhibitor leptomycin B, demonstrating constitutive shuttling of NF-kappa B between the cytoplasm and nucleus. Blocking NF-kappa B shuttling inhibited KC transcription. KC induced p65 phosphorylation, which was critical for NF-kappa B activation as determined with the Gal-4-p65 fusion protein and mutation of p65 phosphorylation sites. In conclusion, low...Continue Reading

References

Jun 1, 1997·Trends in Neurosciences·L A O'Neill, C Kaltschmidt
Apr 1, 1997·Seminars in Cancer Biology·M J May, S Ghosh
May 20, 1998·Proceedings of the National Academy of Sciences of the United States of America·K T AkamaL J Van Eldik
Jan 16, 1999·The Journal of Biological Chemistry·L A KrushelK L Crossin
Apr 6, 1999·Journal of Neurovirology·M Q Xia, B T Hyman
Apr 10, 1999·Nature Neuroscience·J KangM Nedergaard
Oct 16, 1999·The Journal of Biological Chemistry·H SakuraiW Toriumi
Oct 26, 1999·Trends in Neurosciences·V C Asensio, I L Campbell
Feb 3, 2000·Proceedings of the National Academy of Sciences of the United States of America·T T HuangS Miyamoto
Oct 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·Y LuoM E Dorf
Jan 3, 2001·The Journal of Clinical Investigation·A S Baldwin
Jan 3, 2001·The Journal of Clinical Investigation·P P Tak, G S Firestein
Feb 13, 2001·The Journal of Clinical Investigation·Y Yamamoto, R B Gaynor
Mar 14, 2001·Trends in Biochemical Sciences·M L SchmitzM Kracht
Nov 10, 2001·Science·D H MauchF W Pfrieger
Dec 1, 2001·Nature Medicine·T LawrenceD A Willoughby
Dec 12, 2001·The Journal of Biological Chemistry·Bansri FuriaFatah Kashanchi
Dec 18, 2001·Nature Immunology·Simona SaccaniGioacchino Natoli
Jan 12, 2002·Current Opinion in Pharmacology·Knut BiberHendrikus W G M Boddeke
Jan 22, 2002·The Journal of Biological Chemistry·Andreas BirbachJohannes A Schmid
May 2, 2002·Cell·Sankar Ghosh, Michael Karin
May 3, 2002·Nature·Hongjun SongFred H Gage
May 11, 2002·Nature Reviews. Cancer·Michael KarinZhi-Wei Li

❮ Previous
Next ❯

Citations

Dec 31, 2010·Journal of Neurotrauma·Jeffrey T ColeWilliam D Watson
Feb 24, 2016·Frontiers in Microbiology·Bolong LiuShao-Jun Tang
Oct 7, 2004·Brain Research. Developmental Brain Research·David V PowPaul B Colditz
Sep 26, 2006·Biochemical Pharmacology·Sylvie Mémet
Dec 29, 2020·Pharmacology & Therapeutics·Tomasz P MikolajczykTomasz J Guzik

❮ Previous
Next ❯

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.